Neogen (NEOG) EBITDA Margin Growth (3y) (2013 - 2026)
Neogen (NEOG) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,505.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -763.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -184.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -875.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -875.00 |
| Nov 30, 2025 | 94.00 |
| Aug 31, 2025 | -1,227.00 |
| May 31, 2025 | -28,396.00 |
| Feb 28, 2025 | -253.00 |
| Nov 30, 2024 | -20,738.00 |
| Aug 31, 2024 | -1,591.00 |
| May 31, 2024 | -1,039.00 |
| Feb 29, 2024 | -826.00 |
| Nov 30, 2023 | -1,044.00 |
| Aug 31, 2023 | 1,015.00 |
| May 31, 2023 | -860.00 |
| Feb 28, 2023 | -587.00 |
| Nov 30, 2022 | -2,028.00 |
| Aug 31, 2022 | -1,146.00 |
| May 31, 2022 | -420.00 |
| Feb 28, 2022 | -1,001.00 |
| Nov 30, 2021 | -748.00 |
| Aug 31, 2021 | 41.00 |
| May 31, 2021 | -247.00 |